Ahi Evran University Education and Research Hospital   Report issue

Academic/Hospital Phase 4
Founded: Kırşehir Turkey (2006)

Organization Overview

First Clinical Trial
2011
NCT02029456
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Ahi Evran University Education and Research Hospital | Ahi Evran University Faculty of Health Sciences | Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital | Ahi Evren Thoracic and Cardiovascular Surgery Hospital | ahi Evren thoracic and cardiovascular surgery training and research hospital | Department of Cardiology, Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital | İSMAİL CEYLAN | Kirsehir Ahi Evran Universitesi | Kırşehir Ahi Evran University School of Physical Therapy and Rehabilitation | Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital

Active Ingredients

Drugs in Phase 4 Trials (2)

alteplase (Activase) (1 trial)

dextrose (1 trial)

Drugs in Other Trials (3)

bupivacaine (Exparel) (1 trial)

epinephrine (levophed) (1 trial)

ozone (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Embolism (Phase 4)

Pulmonary Embolism (Phase 4)

Tennis Elbow (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5